12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO, CA
Investor Presentation
Announces the Appointment of Dan Weng, M.D., to Board of Directors
Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update
Shareholder votes
News, Underwriting Agreement, Legal Opinion
Reports First Quarter 2025 Financial Results and Provides Business Update
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
RW
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Definitive Merger Proxy Statement
PRER14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload